Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
17.97 USD | -0.33% | -4.11% | -21.97% |
05-10 | UBS Adjusts Privia Health Group Price Target to $26.50 From $29, Maintains Buy Rating | MT |
05-09 | Transcript : Privia Health Group, Inc., Q1 2024 Earnings Call, May 09, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-21.97% | 2.14B | |
+20.68% | 85.55B | |
-29.31% | 70.07B | |
+5.99% | 28.95B | |
-8.63% | 17.51B | |
+1.57% | 17.39B | |
+0.39% | 15.38B | |
+6.47% | 13.4B | |
+68.09% | 12.93B | |
+4.90% | 12.77B |
- Stock Market
- Equities
- PRVA Stock
- News Privia Health Group, Inc.
- UBS Adjusts Privia Health Price Target to $35 From $30, Maintains Buy Rating